Global Information
회사소개 | 문의 | 비교리스트

미국의 의료용 마리화나 시장과 예측(-2022년)

US Medical Marijuana Market, Forecast to 2022

리서치사 Frost & Sullivan
발행일 2018년 07월 상품 코드 670596
페이지 정보 영문 98 Pages
US $ 3,000 ₩ 3,615,000 Web Access (Regional License) help
리서치사의 웹사이트에 로그인할 수 있는 패스워드가 발급되며, PDF를 다운로드 받는 형태로 제공됩니다. 동일 국가 내에 있는 사업장의 모든 분들이 이용할 수 있는 라이선스이며, 이용 인원수 제한은 없습니다. 텍스트 등의 PDF 내용 편집은 불가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

미국의 의료용 마리화나 시장과 예측(-2022년) US Medical Marijuana Market, Forecast to 2022
발행일 : 2018년 07월 페이지 정보 : 영문 98 Pages

미국의 의료용 마리화나(Medical Marijuana) 시장을 분석했으며, 시장 개요, 경쟁 구도, 시장 성장 촉진요인 및 억제요인, 의료용 마리화나 시장 전체 및 부문별(의료용 대마, 칸나비디올(CBD)) 시장 분석과 예측 등의 정보를 정리하여 전해드립니다.

제1장 주요 요약

제2장 시장 개요

제3장 경쟁 플레이북

  • FDA 승인 대마 합성 제품
  • 시장 기회
  • 혁신적인 시장 진출기업
  • 조사결과 평가
  • 민간기업의 에퀴티(equity) 계약

제4장 성장 촉진요인 및 억제요인 : 의료용 마리화나 시장 전체

  • 성장 촉진요인
  • 성장 촉진요인 설명
  • 성장 억제요인
  • 성장 억제요인 설명

제5장 예측과 동향 : 의료용 마리화나 시장 전체

  • 예측 전제조건과 정의
  • 조사 방법 및 예측 전제조건
  • 의료용 마리화나 시장 : 개요
  • 의료용 대마 매출 : 주(州)별
  • 의료용 마리화나 예측 : 부문별
  • 매출 예측 논의

제6장 의료용 대마 부문

  • 의료용 대마 주요 조사결과
  • 의료용 마리화나 산업 에코시스템에서의 전환
  • 의료용 대마 : 지역 도표
  • 의료용 대마 : 주(州)별 환자수
  • 시장 엔지니어링 메트릭스
  • 의료용 대마 매출 예측
  • 매출 예측 논의
  • 매출 예측 : 2차 부문별
  • 매출 예측 : 2차 부문별 논의

제7장 칸나비디올(CBD) 부문

  • CBD 주요 조사결과
  • 시장 엔지니어링 메트릭스
  • CBD 매출 예측
  • 매출 예측 논의
  • 매출 예측 : 2차 부문별
  • 매출 예측 : 2차 부문별 논의

제8장 결론

제9장 부록


LSH 18.08.14

Medical Cannabis Revenue will Overtake Recreational in the Next 4 Years

The medical marijuana market is growing in the United States despite the fact that the Food and Drug Administration (FDA) has not yet approved any medical marijuana products. These marijuana-based products have not yet passed through the rigorous tests and clinical trials required for medical drug approvals in the United States. At the Federal level, marijuana is still considered an illegal Schedule 1 drug. Individual states, however, have laws in place for the legal use of medical marijuana, and in some states, for the use of recreational marijuana. Cannabidiol (CBD) products are also legally available in some US states as well as in many other countries. The market generates a lot of money, though much of that money is still considered a black market.

Many business segments are involved with the development of the medical marijuana market. Some businesses directly touch the plant product, such as growers, packers, transporters, and sellers. Other businesses operate in the medical marijuana industry but do not touch the plant product, including legal services, marketing and brand services, data and analytical services, insurance participants and hardware or software companies. The rules differ depending upon where a company stands related to the marijuana plant. This is a very different model than is in place for traditional pharmaceutical products.

The medical marijuana segment of the marijuana industry includes marijuana plant products, CBD products, and synthetically derived products targeting the cannabidiol receptors CB1 and CB2. There are several synthetic products currently on the markets in many countries other than the US. As a matter of fact, in Canada, not only is medical marijuana approved for use on the national level, its use is covered by Health Canada, the national government insurance plan.

In the US, medical marijuana use is increasing, as many more states have approved it for use in several diseases. In addition, hundreds of clinical trials are underway, testing products under the watchful eye of the FDA. It has been reported in states where medical marijuana is approved for use for the treatment of pain, there have reductions in the use of opioid drugs. This decrease in opioid use may prove to be a valuable mechanism to curb the current opioid epidemic in the US.

Legal uncertainty related to the use of medical marijuana has limited big pharma investments into this space; however in non-US locations, companies are more interested in pursuing this area of research and development. Billions of dollars are being generated through this market. It is a growing market drawing keen interest from physicians, investors and regulators. Physician education will be crucial, as these products gain approval, as cannabis was not a part of the medical curriculum of many currently practicing physicians.

Table of Contents


  • Key Findings
  • Key Findings (continued)
  • Key Findings (continued)
  • Scope and Segmentation
  • Key Questions this Study will Answer
  • Cannabis Segment Overview
  • CBD Segment Overview
  • Marijuana Market-Definitions and Market Segments
  • Market Engineering Measurements
  • Market Engineering Measurements (continued)
  • Companies to Watch
  • 3 Big Predictions


  • Cannabis Primer
  • Cannabinoids
  • Endocannabinoid System
  • Hemp Derived CBD Market
  • Federal Laws Regarding Cannabis & CBD Regulation
  • Federal Laws Regarding Cannabis & CBD Regulation (continued)
  • Federal Laws Regarding Cannabis & CBD Regulation (continued)
  • Federal Laws Regarding Hemp Regulation
  • Federal Oversight in Medical Cannabis Industry
  • Medical Cannabis-Federal versus State Regulations*
  • State-Specific Approved Marijuana/CBD Use
  • State-Specific Approved Marijuana/CBD Use (continued)
  • Medical Marijuana Business Sector Landscape
  • Medical Cannabis
  • Medical Cannabis Impact on Opioid Use
  • Cannabidiol (CBD)
  • CBD Impact on Healthcare Treatments
  • Cannabinoid (CB1 & CB2) Drugs in Development
  • Cannabinoid Drugs in Development (continued)
  • Cannabinoid Drugs in Development (continued)
  • Cannabinoid Drugs in Development (continued)
  • Cannabinoid Drugs in Development (continued)
  • 2018 Marijuana Conferences


  • FDA-Approved Cannabinoid-Based Synthetic Products
  • Market Opportunities
  • Disruptive Market Participants
  • Funding Assessment
  • Funding Assessment (continued)
  • Private Company Equity Deals
  • Private Company Equity Deals (continued)


  • Market Drivers
  • Drivers Explained
  • Drivers Explained (continued)
  • Market Restraints
  • Restraints Explained
  • Restraints Explained (continued)


  • Forecast Assumptions and Definitions
  • Methodology and Forecast Assumptions
  • Medical Marijuana Market-An Overview
  • Medical Cannabis Revenue by State
  • Medical Marijuana Forecast by Segment
  • Revenue Forecast Discussion


  • Key Findings for Medical Cannabis
  • Transformation in the Medical Marijuana Industry Ecosystem, 2018
  • Medical Cannabis-Regional Picture
  • Medical Cannabis-Patients by State
  • Market Engineering Metrics
  • Medical Cannabis Revenue Forecast
  • Revenue Forecast Discussion
  • Revenue Forecast by Sub-segment
  • Revenue Forecast by Sub-segment Discussion


  • Key Findings for CBD
  • Market Engineering Metrics
  • CBD Revenue Forecast to 2022
  • Revenue Forecast Discussion
  • CBD Sub-segment Revenue Forecast
  • Revenue Forecast by Sub-segment Discussion


  • The Last Word-3 Big Predictions
  • Legal Disclaimer


  • Appendix-List of Marijuana Industry Keywords & Acronyms
  • List of Exhibits
  • List of Exhibits (continued)
  • List of Exhibits (continued)


  • The Frost & Sullivan Story
  • Value Proposition-Future of Your Company & Career
  • Global Perspective
  • Industry Convergence
  • 360° Research Perspective
  • Implementation Excellence
  • Our Blue Ocean Strategy
Back to Top
전화 문의